Metronidazole
Who holds supplier records for Metronidazole? 4 organisations hold a current record for Metronidazole: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Italy (1) and India (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Metronidazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/metronidazole
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Metronidazole expires 4 Oct 2039. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Metronidazole. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CORDEN PHARMA BERGAMO SPAItalyCEP Company GMP cert on recordActive DMF 3609 · latest filing Sept 1979
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 16263, 5783 · latest filing Nov 2002
- Wuhan Wuyao Pharmaceutical Co., Ltd.ChinaCEPInactive DMF 23421 · latest filing Dec 2009
- HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Metronidazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2001-450 - Rev 11 Metronidazole | Jul 2026 | — |
| CORDEN PHARMA BERGAMO S.P.A. Treviglio | IT | CEP 1995-052 - Rev 03 Metronidazole | Feb 2026 | Inspected Apr 2024 Italy |
| WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi City | CN | CEP 2024-218 - Rev 00 Metronidazole, Micronised | Jul 2024 | — |
| HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD. Fengshan Town | CN | CEP 2018-264 - Rev 02 Metronidazole, Process II | Mar 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Metronidazole are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- HUBEI HONGYUAN PHARMACEUTICAL CO LTDInactive DMF 26658 · filed Nov 2012
- China · Inactive DMF 19442 · filed Mar 2006
- TIANJIN ZHONGAN PHARMACEUTICAL CO LTDInactive DMF 16380 · filed Jan 2003
- Poland · Inactive DMF 9294 · filed Aug 1991
- TIANJIN HEBEI PHARMACEUTICAL FACTORYInactive DMF 4927 · filed May 1983
- MEDIMPEX NORTH AMERICA INCInactive DMF 4672 · filed Oct 1982
- India · Inactive DMF 3675 · filed Dec 1979
- COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS SARLInactive DMF 2186 · filed Nov 1973
- RHONE POULENC INCInactive DMF 780 · filed Feb 1964
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (59 listed products contain Metronidazole). The latest listed patent expires 4 Oct 2039. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Metronidazole is a nitroimidazole antibiotic medication used for the treatment of anaerobic bacterial and protozoal infections. It acts by inhibiting nucleic acid synthesis by disrupting the DNA of microbial cells.
Chemical identity
- IUPAC name
- 2-(2-methyl-5-nitroimidazol-1-yl)ethanol
- Canonical SMILES
- CC1=NC=C(N1CCO)[N+](=O)[O-]
- InChIKey
- VAOCPAMSLUNLGC-UHFFFAOYSA-N
- Synonyms
- Flagyl API, metronidazole, Metronidazol, Gineflavir, 2-Methyl-5-nitroimidazole-1-ethanol, Deflamon, Orvagil, Anagiardil, Trichazol, MetroGel, Bayer 5360, Sanatrichom
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nitroimidazole Antimicrobial
- Chemical structure
- Nitroimidazoles
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Metronidazole?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Metronidazole: CORDEN PHARMA BERGAMO SPA (Italy), Unichem Laboratories Ltd. (India), Wuhan Wuyao Pharmaceutical Co., Ltd. (China) and HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Metronidazole Drug Master Files are active?
CORDEN PHARMA BERGAMO SPA (DMF 3609) and Unichem Laboratories Ltd. (DMF 16263, 5783). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Metronidazole records mean?
9 organisations have only inactive Type II DMFs for Metronidazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Metronidazole have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Metronidazole on the EDQM register, including UNICHEM LABORATORIES LIMITED Mumbai (IN), CORDEN PHARMA BERGAMO S.P.A. Treviglio (IT), WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi City (CN) and HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD. Fengshan Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Metronidazole?
Yes. The latest patent listed for an approved US product containing Metronidazole expires 4 Oct 2039, across 59 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Metronidazole supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Metronidazole?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.